Measurement and valuation of the attributes of innovation of healthcare technologies: a systematic review (Englisch)
Freier Zugriff
- Neue Suche nach: Syeed, M. Sakil
- Neue Suche nach: Poudel, Nabin
- Neue Suche nach: Ngorsuraches, Surachat
- Neue Suche nach: Diaz, Jose
- Neue Suche nach: Chaiyakunapruk, Nathorn
- Neue Suche nach: Syeed, M. Sakil
- Neue Suche nach: Poudel, Nabin
- Neue Suche nach: Ngorsuraches, Surachat
- Neue Suche nach: Diaz, Jose
- Neue Suche nach: Chaiyakunapruk, Nathorn
In:
Journal of Medical Economics
;
25
, 1
;
1176-1184
;
2022
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Measurement and valuation of the attributes of innovation of healthcare technologies: a systematic review
-
Beteiligte:Syeed, M. Sakil ( Autor:in ) / Poudel, Nabin ( Autor:in ) / Ngorsuraches, Surachat ( Autor:in ) / Diaz, Jose ( Autor:in ) / Chaiyakunapruk, Nathorn ( Autor:in )
-
Erschienen in:Journal of Medical Economics ; 25, 1 ; 1176-1184
-
Verlag:
- Neue Suche nach: Taylor & Francis
-
Erscheinungsdatum:31.12.2022
-
Format / Umfang:9 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 25, Ausgabe 1
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Oncology drugs and added benefit: insights from 3 European health technology assessment agencies on the role of efficacy endpointsSmith, Nathaniel / Fu, An-Chen / Fisher, Tim / Meletiche, Dennis / Pawar, Vivek et al. | 2022
- 7
-
Changes in prescription pain medication and intra-articular corticosteroid utilization after intra-articular bio-fermentation derived hyaluronic acid use in patients undergoing multimodal pain managementNicholls, Mathew / Niazi, Faizan / Nelson, Winnie W. / Lau, Edmund / Kurtz, Steven M. / Ong, Kevin L. et al. | 2022
- 14
-
Health state utilities associated with weight loss in type 2 diabetes and obesityBoye, Kristina S. / Matza, Louis S. / Stewart, Katie D. / Andrews, Haylee / Howell, Timothy A. / Stefanski, Adam / Malley, Karen G. / Ishak, K. Jack / Fernández Landó, Laura et al. | 2022
- 26
-
Incremental net monetary benefit of herpes zoster vaccination: a systematic review and meta-analysis of cost-effectiveness evidenceUdayachalerm, Sariya / Renouard, Maranda G. / Anothaisintawee, Thunyarat / Thakkinstian, Ammarin / Veettil, Sajesh K. / Chaiyakunapruk, Nathorn et al. | 2022
- 38
-
Estimation of the cost of influenza antiviral medication guidance or support provided by healthcare professionals: a questionnaire survey in JapanKurazono, Kenji / Ikeoka, Hidetoshi / Hiroi, Shinzo / Iwasaki, Kosuke / Takeshima, Tomomi / Akazawa, Manabu et al. | 2022
- 51
-
Assessing health-related quality-of-life in patients with symptomatic obstructive hypertrophic cardiomyopathy: EQ-5D-based utilities in the EXPLORER-HCM trialXie, Jipan / Wang, Yan / Xu, Yaping / Fine, Jennifer T. / Lam, Jenny / Garrison, Louis P. et al. | 2022
- 59
-
Cost-effectiveness of 4 mg dibotermin alfa/absorbable collagen sponge versus iliac crest bone graft for lumbar degenerative disc disease in the United KingdomCumming, David / Song, Fujian / Taylor, Rod S. / Zahra, Mehdi / Williams, Adrian / Eggington, Simon et al. | 2022
- 66
-
Quality of life study for caregivers of people with uncontrolled focal-onset seizuresSoare, Ioana-Alexandra / Flint, India / Savic, Natasa / Puricelli, Fiorenza / Medjedovic, Jasmina / O’Flaherty, Ewa Drogon / James, Samuel / Longworth, Louise et al. | 2022
- 77
-
Budget impact analysis of transcatheter aortic valve replacement in low, intermediate, and high-risk patients with severe aortic stenosis in Saudi ArabiaCarapinha, João L. / Al-Omar, Hussain A. / Alqoofi, Faisal / Samargandy, Sondos A. / Candolfi, Pascal et al. | 2022
- 87
-
The incidence and economic burden of extrapyramidal symptoms in patients with schizophrenia treated with second generation antipsychotics in a Medicaid populationKadakia, Aditi / Brady, Brenna L. / Dembek, Carole / Williams, G. Rhys / Kent, Justine M. et al. | 2022
- 99
-
Cost-effectiveness of brentuximab vedotin for relapsed or refractory systemic anaplastic large-cell lymphoma in ChinaLiu, Jia / Zheng, Lei / Chuang, Ling-Hsiang et al. | 2022
- 108
-
Real-world burden of chemotherapy-induced myelosuppression in patients with small cell lung cancer: a retrospective analysis of electronic medical data from community cancer care providersEpstein, Robert S. / Weerasinghe, Roshanthi K. / Parrish, Amy S. / Krenitsky, JoAnn / Sanborn, Rachel E. / Salimi, Tehseen et al. | 2022
- 119
-
The societal economic value of COVID-19 vaccines in the United StatesKirson, Noam / Swallow, Elyse / Lu, Jessica / Mesa-Frias, Marco / Bookhart, Brahim / Maynard, Josie / Shivdasani, Yashna / Lefebvre, Patrick et al. | 2022
- 129
-
Cost-effectiveness analysis of carbetocin versus oxytocin for the prevention of postpartum hemorrhage following vaginal birth in the United KingdomMatthijsse, Suzette / Andersson, Fredrik L. / Gargano, Michael / Yip Sonderegger, Yum L. et al. | 2022
- 138
-
Cost impact analysis of novel host-response diagnostic for patients with community-acquired pneumonia in the emergency departmentSchneider, John E. / Cooper, Jacie T. et al. | 2022
- 152
-
The impact of lurasidone on functioning and indirect costs in adults with bipolar depression: a post-hoc analysisNiu, Xiaoli / Dembek, Carole / Fan, Qi / Mao, Yongcai / Divino, Victoria / Burch, Steven / Tocco, Michael et al. | 2022
- 160
-
Clinical and economic benefits of lenzilumab plus standard of care compared with standard of care alone for the treatment of hospitalized patients with COVID-19 in the United States from the hospital perspectiveKilcoyne, Adrian / Jordan, Edward / Zhou, Allen / Thomas, Kimberly / Pepper, Alicia N. / Chappell, Dale / Amarapala, Miyuru / Hughes, Avery / Thompson, Melissa et al. | 2022
- 172
-
Patient profiles, initial hospital encounter characteristics, and hospital re-encounters of patients with a hospital emergency department visit or inpatient admission for major depressive disorderZhang, Qiaoyi / O’Hara, Marguerite / McCormick, Carter / Lingohr-Smith, Melissa / Borentain, Stephane / Mathews, Maju / Joshi, Kruti / Anjo, Joana / Lin, Jay et al. | 2022
- 182
-
Incidence of corneal adverse events in patients with multiple myeloma and their clinical and economic impact: A real-world retrospective cohort studyWang, Feng / Sansbury, Leah / Ferrante, Shannon / Maiese, Eric M. / Willson, Jenny / Chen, Chi-Chang / Nunna, Sasikiran / Sun, Kainan / Kleinman, David M. et al. | 2022
- 193
-
Economic burden of attention-deficit/hyperactivity disorder among children and adolescents in the United States: a societal perspectiveSchein, Jeff / Adler, Lenard A. / Childress, Ann / Cloutier, Martin / Gagnon-Sanschagrin, Patrick / Davidson, Mikhaïl / Kinkead, Frédéric / Guerin, Annie / Lefebvre, Patrick et al. | 2022
- 206
-
Impact of reimbursement restriction on drug market sales under the National Health Insurance in JapanMamiya, Hiroaki / Igarashi, Ataru et al. | 2022
- 212
-
Epidemiology and economic burden of Huntington’s disease: a Canadian provincial public health system perspectiveShaw, Eileen / Mayer, Michelle / Ekwaru, Paul / McMullen, Suzanne / Graves, Erin / Wu, Jennifer W. / Budd, Nathalie / Maturi, Bridget / Cowling, Tara / Mestre, Tiago A. et al. | 2022
- 220
-
The impact of omalizumab on paid and unpaid work productivity among severe Japanese cedar pollinosis (JCP) patientsMüller, M. / Igarashi, A. / Hashiguchi, K. / Kappel, M. / Paolini, F. / Yoshisue, H. / Funakubo, M. / Sharma, H. / Okano, M. et al. | 2022
- 230
-
Mean lifetime survival estimates following solid organ transplantation in the US and UKGraham, Christopher N. / Watson, Crystal / Barlev, Arie / Stevenson, Matt / Dharnidharka, Vikas R. et al. | 2022
- 238
-
Evaluation of the cost and medical resource use outcomes associated with nasal glucagon versus injectable glucagon for treatment of severe hypoglycemia in people with diabetes in Canada: a modeling analysisYale, Jean-François / Osumili, Beatrice / Mitchell, Beth D. / Hunt, Barnaby / Sohi, Gurjeev / Jeddi, Mark / Mojdami, Donna / Valentine, William J. et al. | 2022
- 249
-
Quantifying the economic effects of ravulizumab versus eculizumab treatment in patients with atypical hemolytic uremic syndromeLevy, Adrian R. / Chen, Peter / Johnston, Karissa / Wang, Yan / Popoff, Evan / Tomazos, Ioannis et al. | 2022
- 260
-
How accurate are the longer-term projections of overall survival for cancer immunotherapy for standard versus more flexible parametric extrapolation methods?Cooper, Miranda / Smith, Sarah / Williams, Troy / Aguiar-Ibáñez, Raquel et al. | 2022
- 274
-
Evaluating the cost utility of racecadotril in addition to oral rehydration solution versus oral rehydration solution alone for children with acute watery diarrhea in four low middle-income countries: Egypt, Morocco, Philippines and VietnamRautenberg, Tamlyn Anne / Downes, Martin / Kiet, Pham Huy Tuan / Ashoush, Nermeen / Dennis, Antonio Rosete / Kim, Kyoo et al. | 2022
- 282
-
Journal of Medical Economics in review: the best of 2021Abraham, Ivo / Lee, Kenneth K. C. / Gregg, Mike et al. | 2022
- 287
-
Real-world retrospective analysis of patient characteristics, healthcare resource utilization, costs, and treatment patterns among unvaccinated adults with COVID-19 diagnosed in outpatient settings in the United StatesScott, Amie / Chambers, Richard / Reimbaeva, Maya / Atwell, Jessica / Baillon-Plot, Nathalie / Draica, Florin / Tarallo, Miriam et al. | 2022
- 299
-
Clinical and economic burden of HPV-related cancers in the US veteran populationSaxena, Kunal / Dawson, Rachel Souza / Cyhaniuk, Anissa / Bello, Temitope / Janjan, Nora et al. | 2022
- 309
-
Cost-effectiveness of andexanet alfa versus four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-related intracranial hemorrhage in the USFanikos, John / Goldstein, Joshua N. / Lovelace, Belinda / Beaubrun, Anne C. / Blissett, Robert S. / Aragão, Filipa et al. | 2022
- 321
-
The notion of Surrogacy in Health Technology Assessment: an insight in the processes of Germany, UK and FrancePetrou, Panagiotis / Pitsillidou, Olga / Postma, M. J. et al. | 2022
- 324
-
Cost-effectiveness of brentuximab vedotin plus chemotherapy for previously untreated CD30-positive peripheral T-cell lymphoma in CanadaZou, Denise / Lee, Joseph / Kansal, Anuraag / Ma, Wenkang / Harris, Mack / Lisano, Julie / Fenton, Keenan / Yu, Kristina S. et al. | 2022
- 334
-
COVID-19-associated hospitalizations among children less than 12 years of age in the United StatesDi Fusco, Manuela / Vaghela, Shailja / Moran, Mary M. / Lin, Jay / Atwell, Jessica E. / Malhotra, Deepa / Scassellati Sforzolini, Thomas / Cane, Alejandro / Nguyen, Jennifer L. / McGrath, Leah J. et al. | 2022
- 347
-
Cost-effectiveness and potential value of pharmaceutical treatment of nonalcoholic fatty liver diseaseRustgi, Vinod K. / Duff, Steve B. / Elsaid, Mohamed I. et al. | 2022
- 356
-
How the cost-effectiveness results change in the China health policy environment: an economic evaluation of glycopyrrolate/formoterol for the treatment of COPDWang, Luying / Gu, Weili / Zhang, Xiao / Fu, Shihui / Zhang, Donger / Guan, Xin / Li, Hongchao / Ma, Aixia et al. | 2022
- 367
-
Evaluation of treatment patterns, healthcare resource utilization, and costs among patients receiving treatment for cytomegalovirus following allogeneic hematopoietic cell or solid organ transplantationCheng, Wendy Y. / Avery, Robin K. / Thompson-Leduc, Philippe / Cheung, Hoi Ching / Bo, Tien / Duh, Mei Sheng / Hirji, Ishan et al. | 2022
- 381
-
Hospital care and medical costs of septic arthritis in Spain: a retrospective multicenter analysisDarbà, Josep / Marsà, Alicia et al. | 2022
- 386
-
Association of factor expression levels with health-related quality of life and direct medical costs for people with haemophilia BBurke, Tom / Shaikh, Anum / Ali, Talaha M. / Li, Nanxin / Curtis, Randall / Garcia Diego, Daniel-Anibal / Recht, Michael / Sannie, Thomas / Skinner, Mark / O’Hara, Jamie et al. | 2022
- 393
-
The PRIME Type 2 Diabetes Model: a novel, patient-level model for estimating long-term clinical and cost outcomes in patients with type 2 diabetes mellitusPollock, Richard F. / Norrbacka, Kirsi / Boye, Kristina S. / Osumili, Beatrice / Valentine, William J. et al. | 2022
- 403
-
Reflex single-gene non-invasive prenatal testing is associated with markedly better detection of fetuses affected with single-gene recessive disorders at lower costRiku, Shan / Hedriana, Herman / Carozza, Jacqueline A. / Hoskovec, Jennifer et al. | 2022
- 412
-
Urinary catheter monitoring of intra-abdominal pressure after major abdominal surgery, a cost-benefit analysisNey, John P. / Moll, Vanessa / Kimball, Edward J. et al. | 2022
- 421
-
Modification of treatment-sequence model with a customizable number of treatments to better reflect contemporary and future clinical practice in moderate to severe psoriasisvan de Wetering, Gijs / Ignacio, Tim / Dhanda, Devender / Patel, Vardhaman / Zhang, Yuanhui / Zhuo, Joe et al. | 2022
- 428
-
Oral misoprostol tablets (25 µg) for induction of labor: a targeted literature review and cost analysisPoinas, Anne-Claire / Padgett, Katherine / Heus, Roel de / Perrotin, Franck / Devlieger, Roland et al. | 2022
- 437
-
How China controls the Covid-19 epidemic through public health expenditure and policy?Jin, Hui / Li, Baoyang / Jakovljevic, Mihajlo et al. | 2022
- 450
-
Dapagliflozin cost-effectiveness analysis in heart failure patients in EgyptAbdelhamid, Magdy / Elsisi, Gihan Hamdy / Seyam, Ahmed / Shafie, Ahmed / Kirollos, Mary / Emad, Sandy / Mansy, Shady / Sobhy, Mohamed et al. | 2022
- 457
-
Total cost of testing for genomic alterations associated with next-generation sequencing versus polymerase chain reaction testing strategies among patients with metastatic non-small cell lung cancerVanderpoel, Julie / Stevens, Andrea L. / Emond, Bruno / Lafeuille, Marie-Hélène / Hilts, Annalise / Lefebvre, Patrick / Morrison, Laura et al. | 2022
- 469
-
Cost-effectiveness of pembrolizumab for the first-line treatment of patients with unresectable or metastatic MSI-H/dMMR colorectal cancer in the United StatesAguiar-Ibáñez, Raquel / Hardern, Chloë / van Hees, Frank / Lee, Dawn / Patel, Anubhav / Chhabra, Nitika / Baluni, Gargi / Amonkar, Mayur / Lai, Yizhen / Xu, Ruifeng et al. | 2022
- 481
-
A discrete choice experiment investigating HIV testing preferences in South AfricaChiwire, P. / Mühlbacher, A. C. / Evers, S. M. / Mahomed, H. / Ostermann, J. / Hiligsmann, M. et al. | 2022
- 491
-
Economic evaluation of a JAK inhibitor compared to a monoclonal antibody for treatment of moderate-to-severe atopic dermatitis from a UK perspectiveHeinz, Katja C. / Willems, Damon / Hiligsmann, Mickaël et al. | 2022
- 503
-
Economic and clinical impact of a novel, light-based, at-home antiviral treatment on mild-to-moderate COVID-19Gibson, Scott / Saunders, Rhodri / Stasko, Nathan / Bickerstaff, Cherrishe-Brown / Oakley, John / Osterman, Mark / Torres, Rafael Torrejon / Kish, Jonathan K. / Feinberg, Bruce A. / Emerson, David et al. | 2022
- 515
-
US payer budget impact of a microarray assay with machine learning to evaluate kidney transplant rejection in for-cause biopsiesFusfeld, Lauren / Menon, Sreeranjani / Gupta, Gaurav / Lawrence, Christopher / Masud, Salwa F. / Goss, Thomas F. et al. | 2022
- 524
-
Carbon footprint and associated costs of asthma exacerbation care among UK adultsKponee-Shovein, Kalé / Marvel, Jessica / Ishikawa, Ryotaro / Choubey, Abhay / Kaur, Harneet / Thokala, Praveen / Ngom, Khadidja / Fakih, Iman / Schatzki, Todd / Signorovitch, James et al. | 2022
- 532
-
Impact of timing of nintedanib initiation among patients newly diagnosed with idiopathic pulmonary fibrosisSinger, David / Bengtson, Lindsay G. S. / Conoscenti, Craig S. / Anderson, Amy J. / Brekke, Lee / Shetty, Sharash S. / de Andrade, Joao et al. | 2022
- 541
-
Cost-effectiveness of axicabtagene ciloleucel versus lisocabtagene maraleucel for adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy in the USOluwole, Olalekan O. / Liu, Rongzhe / Diakite, Ibrahim / Feng, Chaoling / Patel, Anik / Nourhussein, Iman / Snider, Julia Thornton / Locke, Frederick L. et al. | 2022
- 552
-
The relationship between cost and the recommendation, refusal, and discontinuation of treatment for chronic myeloid leukemia and multiple myeloma in Japan: a cross-sectional exploratory surveyMunakata, Taro / Handa, Yutaka / Mizuno, Toru / Tomiuchi, Nobuko / LoPresti, Michael / Shimizu, Junichi et al. | 2022
- 561
-
Intravenous iron for the treatment of iron deficiency anemia in China: a patient-level simulation model and cost-utility analysis comparing ferric derisomaltose with iron sucroseHu, Shanlian / Liu, Limin / Pollock, Richard F. / Pöhlmann, Johannes / Wu, Depei / Zhang, Yabing et al. | 2022
- 571
-
Methodological similarities and variations among EQ-5D-5L value set studies: a systematic reviewPoudel, N. / Fahim, S. M. / Qian, J. / Garza, K. / Chaiyakunapruk, N. / Ngorsuraches, S. et al. | 2022
- 583
-
Cost-effectiveness of enzalutamide versus apalutamide versus androgen deprivation therapy alone for the treatment of metastatic castration-sensitive prostate cancer in CanadaSaad, Fred / Chilelli, Andrew / Hui, Benny / Muratov, Sergey / Ganguli, Arijit / North, Scott / Shayegan, Bobby et al. | 2022
- 591
-
Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score test in node-positive early breast cancerBerdunov, Vladislav / Millen, Steve / Paramore, Andrew / Hall, Peter / Perren, Timothy / Brown, Rebecca / Griffin, Jane / Reynia, Sarah / Fryer, Nina / Longworth, Louise et al. | 2022
- 605
-
Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United StatesDi Fusco, Manuela / Marczell, Kinga / Deger, Kristen A. / Moran, Mary M. / Wiemken, Timothy L. / Cane, Alejandro / de Boisvilliers, Solène / Yang, Jingyan / Vaghela, Shailja / Roiz, Julie et al. | 2022
- 618
-
Cost-effectiveness analysis of sintilimab + chemotherapy versus camrelizumab + chemotherapy for the treatment of first-line locally advanced or metastatic nonsquamous NSCLC in ChinaRui, Mingjun / Fei, Zhengyang / Wang, Yingcheng / Zhang, Xueke / Ma, Aixia / Sun, Haikui / Li, Hongchao et al. | 2022
- 630
-
Annual indirect cost savings in patients with episodic or chronic migraine: post-hoc analyses from multiple galcanezumab clinical trialsTobin, Joshua / Ford, Janet H. / Tockhorn-Heidenreich, Antje / Nichols, Russell M. / Ye, Wenyu / Bhandari, Rohit / Mi, Xiaojuan / Sharma, Karan / Lipton, Richard B. et al. | 2022
- 640
-
A cost-effectiveness analysis of patiromer for the treatment of hyperkalemia in chronic kidney disease patients with and without heart failure in SpainGonzález-Juanatey, José Ramón / González-Franco, Álvaro / de Sequera, Patricia / Valls, Marta / Ramirez de Arellano, Antonio / Pomares, Elisenda / Nieves, Diana et al. | 2022
- 650
-
The healthcare resource utilization and costs of chronic lung allograft dysfunction following lung transplantation in patients with commercial insurance in the United StatesSheshadri, Ajay / Sacks, Naomi C. / Healey, Bridget / Cyr, Phil / Boerner, Gerhard / Huang, Howard J. et al. | 2022
- 660
-
Cost-effectiveness analysis of nivolumab plus ipilimumab plus two cycles of platinum-doublet chemotherapy versus platinum-doublet chemotherapy alone for first-line treatment of stage IV or recurrent non-small cell lung cancer in the United StatesPolyzoi, Maria / Sandhu, Hera / Maervoet, Johan / Yuan, Yong / Chaudhary, Mohammad A. / Varol, Nebibe / Lee, Adam / Dale, Peter / Jones, Cheryl / Lubinga, Solomon J. et al. | 2022
- 669
-
Stick or twist? Cost-effectiveness of siponimod compared with continuing existing disease-modifying therapies in the treatment of active secondary progressive multiple sclerosis in the UKMontgomery, S. / Woodhouse, F. / Vudumula, U. / Gudala, K. / Duddy, M. / Kroes, M. et al. | 2022
- 679
-
Tezepelumab compared with other biologics for the treatment of severe asthma: a systematic review and indirect treatment comparisonMenzies-Gow, Andrew / Steenkamp, Jason / Singh, Sumeet / Erhardt, Wilma / Rowell, Jennifer / Rane, Pallavi / Martin, Neil / Llanos, Jean Pierre / Quinton, Anna et al. | 2022
- 691
-
Long-term hospital resource utilization and associated costs of care for patients initiating nivolumab in advanced non-small cell lung cancer in FranceGrumberg, Valentine / Chouaïd, Christos / Cotté, François-Emery / Jouaneton, Baptiste / Jolivel, Ronan / Gaudin, Anne-Françoise / Reynaud, Dorothée / Assié, Jean-Baptiste / Borget, Isabelle et al. | 2022
- 700
-
A breath of fresh AIR: reducing the carbon footprint of asthmaHatter, Lee / Bruce, Pepa / Beasley, Richard et al. | 2022
- 703
-
Cost-effectiveness analysis of nivolumab plus ipilimumab versus platinum-doublet chemotherapy for first-line treatment of stage IV or recurrent non-small cell lung cancer in the United StatesBerling, Malin / Chaudhary, Mohammad A. / Yuan, Yong / Varol, Nebibe / Dale, Peter / Testa, Eleonora / Klint, Johan / Lee, Adam / Lubinga, Solomon J. / Penrod, John R. et al. | 2022
- 712
-
Cost-effectiveness analysis of arthroscopic injection of a bioadhesive hydrogel implant in conjunction with microfracture for the treatment of focal chondral defects of the knee – an Australian perspectivePapadopoulos, George / Griffin, Sarah / Rathi, Hemant / Gupta, Amit / Sharma, Bhavna / van Bavel, Dirk et al. | 2022
- 722
-
Healthcare resource utilization and costs in individuals with Huntington’s disease by disease stage in a US populationExuzides, Alex / To, Tu My / Abbass, Ibrahim M. / Ta, Jamie T. / Patel, Anisha M. / Surinach, Andy / Fuller, Rebecca L. M. / Luo, Jia et al. | 2022
- 730
-
Cost-effectiveness analysis of KTE-X19 CAR T therapy versus real-world standard of care in patients with relapsed/refractory mantle cell lymphoma post BTKi in EnglandPetersohn, Svenja / Salles, Gilles / Wang, Michael / Wu, Jim / Wade, Sally W. / Simons, Claire L. / Bennison, Craig / Siddiqi, Rubina / Peng, Weimin / Kloos, Ioana et al. | 2022
- 741
-
Healthcare resource utilization and costs among patients with psoriasis treated with ixekizumab or adalimumab over 2 years of follow-up in real-world settingsBlauvelt, Andrew / Shi, Nianwen / Murage, Mwangi J. / Kern, Scott A. / Somani, Najwa / Burge, Russel / Ridenour, Terri L. / Lew, Carolyn R. / Zimmerman, Nicole M. / Zhu, Baojin et al. | 2022
- 750
-
Does meta-analysis of economic evaluations have the potential to play a role in healthcare decision-making in the United States?Veettil, Sajesh K. / Syeed, M. Sakil / Noviyan, Rini / Thakkinstian, Ammarin / Chaiyakunapruk, Nathorn et al. | 2022
- 755
-
The budget impact of enzyme replacement therapy in type 1 Gaucher disease in the United StatesFarahbakhshian, Sepehr / Inocencio, Timothy J. / Poorman, Gregory / Wright, Ekaterina / Pathak, Ravi Ramesh / Bullano, Michael et al. | 2022
- 762
-
Pricing of HPV tests in Italian tender-based settingsInturrisi, Federica / Berkhof, Johannes et al. | 2022
- 769
-
Ambulatory and hospital care of glaucoma in Spain and associated medical costsDarbà, Josep / Marsà, Alicia et al. | 2022
- 774
-
Cost-effectiveness analysis of the Parkinson’s KinetiGraph and clinical assessment in the management of Parkinson's diseaseChaudhuri, K. Ray / Hand, Annette / Obam, Fallon / Belsey, Jonathan et al. | 2022
- 783
-
Limitations of standard cost-effectiveness methods for health technology assessment of treatments for rare, chronic diseases: a case study of treatment for cystic fibrosisRubin, Jaime L. / Lopez, Andrea / Booth, Jason / Gunther, Penilla / Jena, Anupam B. et al. | 2022
- 792
-
National and regional description of healthcare measures among adult Medicaid beneficiaries with schizophrenia within the United StatesPatel, Charmi / Pilon, Dominic / Gupta, Deepshekhar / Morrison, Laura / Lafeuille, Marie-Hélène / Lefebvre, Patrick / Benson, Carmela et al. | 2022
- 808
-
Assessment of face validity of a disease model of nonsense mutation Duchenne muscular dystrophy: a multi-national Delphi panel studyLandfeldt, Erik / Zhang, Rongrong / Childs, Anne-Marie / Johannsen, Jessika / O'Rourke, Declan / Sejersen, Thomas / Strautmanis, Jurgis / Schara-Schmidt, Ulrike / Tulinius, Mar / Walter, Maggie C. et al. | 2022
- 817
-
Comprehensive genomic profiling in advanced/metastatic colorectal cancer: number needed to test and budget impact of expanded first line useProudman, David / DeVito, Nicholas C. / Belinson, Suzanne / Allo, Mina Alsaraf / Morris, Eric D. / Signorovitch, James / Patel, Anuj K. et al. | 2022
- 826
-
Clinical and economic benefits of hospital drug management rationalizationReligioni, Urszula / Pakulska, Teresa et al. | 2022
- 829
-
A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison ServiceLi, Nannan / Boonen, Annelies / van den Bergh, Joop P. / van Kuijk, Sander M. J. / Wyers, Caroline E. / van Oostwaard, Marsha / Vranken, Lisanne / Bours, Sandrine P. G. / Hiligsmann, Mickaël et al. | 2022
- 840
-
Cost-effectiveness of direct oral anticoagulants compared to low-molecular-weight-heparins for treatment of cancer associated venous thromboembolism in SpainMuñoz, Andrés / Gallardo, Enrique / Agnelli, Giancarlo / Crespo, Carlos / Forghani, Monica / Arumi, Daniel / Fernández de Cabo, Susana / Soto, Javier et al. | 2022
- 848
-
Health care resource utilization in the management of patients with Arginase 1 Deficiency in the US: a retrospective, observational, claims database studyBin Sawad, Aseel / Jackimiec, John / Bechter, Mark / Hull, Michael / Yeaw, Jason / Wang, Yi / Diaz, George A. et al. | 2022
- 857
-
Budget impact analysis of belumosudil for chronic graft-versus-host disease treatment in the United StatesBachier, Carlos R. / Skaar, Jeffrey R. / Dehipawala, Sumudu / Miao, Benjamin / Ieyoub, Jonathan / Taitel, Haya et al. | 2022
- 864
-
Global article collection: essential reads from around the worldJakovljevic, Mihajlo / Tan, Chia Jie / Chaiyakunapruk, Nathorn / Silva Julian, Guilherme / Cheung, Kei Long / Hiligsmann, Mickael / Godman, Brian / Opanga, Sylvia / Scuffham, Paul A. / Gregg, Michael et al. | 2022
- 870
-
Incidence, economic burden, and treatment of acute respiratory tract infection in hematopoietic stem cell transplantation recipients using real world data in Japan: a retrospective claims data analysisWattanakamolkul, Kittima / Nakayama, Yoshikazu et al. | 2022
- 880
-
Cost-effectiveness of a paclitaxel-eluting stent (Eluvia) compared to Zilver PTX for endovascular femoropopliteal interventionGray, William A. / Griffiths, Robert I. / Elroy, Peter W. M. / Amorosi, Stacey L. / McGovern, Alysha M. / Jaff, Michael R. / Akehurst, Ron / Müller-Hülsbeck, Stefan et al. | 2022
- 888
-
QALYs and ambulatory status: societal preferences for healthcare decision makingFreath, Lorna L. / Curry, Alistair S. / Cork, David M. W. / Audhya, Ivana F. / Gooch, Katherine L. et al. | 2022
- 894
-
Comparative value-based pricing of an Ebola vaccine in resource-constrained countries based on cost-effectiveness analysisObeng-Kusi, M. / Erstad, B. / Roe, D. J. / Abraham, I. et al. | 2022
- 903
-
The impact of remission duration on the long-term economic burden of acute myeloid leukemia among patients without hematopoietic stem cell transplant in the United StatesTabah, Ashley / Brady, Brenna L. / Huggar, David / Jariwala-Parikh, Krutika / Huey, Krystal / Copher, Ronda / LeBlanc, Thomas William et al. | 2022
- 912
-
Hospitalization costs of adult community-acquired pneumonia in EnglandCampling, James / Wright, Hannah F. / Hall, Gillian C. / Mugwagwa, Tendai / Vyse, Andrew / Mendes, Diana / Slack, Mary P. E. / Ellsbury, Gillian F. et al. | 2022
- 919
-
The cost-effectiveness of abobotulinumtoxinA (Dysport) and onabotulinumtoxinA (Botox) for managing spasticity of the upper and lower limbs, and cervical dystoniaDanchenko, Natalya / Johnston, Karissa M. / Whalen, John et al. | 2022
- 930
-
Impact of influenza infection on the short- and long-term health of patients with chronic obstructive pulmonary diseaseWallick, Chris / To, Tu My / Korom, Stephan / Masters, HenryIII / Hanania, Nicola A. / Moawad, Dalia et al. | 2022
- 940
-
Impact of choice of inhalers for asthma care on global carbon footprint and societal costs: a long-term economic evaluationKponee-Shovein, Kalé / Marvel, Jessica / Ishikawa, Ryotaro / Choubey, Abhay / Kaur, Harneet / Ngom, Khadidja / Fakih, Iman / Swartz, Natalia / Schatzki, Todd / Signorovitch, James et al. | 2022
- 954
-
Cost-effectiveness of pembrolizumab for the first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma in the United StatesBorse, Rebekah H. / Ramakrishnan, Karthik / Gandhi, Jyotika / Dhankhar, Praveen / Chirovsky, Diana et al. | 2022
- 966
-
Levalbuterol vs. albuterol for hospitalized patients with COPD in China: cost-utility and budget impact analysisChen, Lei / Chen, Xianqiu / Zhi, Canghong / Li, Xuan / Hu, Yang et al. | 2022
- 974
-
Identification of undiagnosed atrial fibrillation using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI) in primary care: cost-effectiveness of a screening strategy evaluated in a randomized controlled trial in EnglandHill, Nathan R. / Groves, Lara / Dickerson, Carissa / Boyce, Rebecca / Lawton, Sarah / Hurst, Michael / Pollock, Kevin G. / Sugrue, Daniel M. / Lister, Steven / Arden, Chris et al. | 2022
- 984
-
Early real-world experience with emicizumab and concomitant factor VIII replacement products in adult males with Hemophilia A without inhibitorsCafuir, Lorraine / Estrin, Adina / Chen, Er / Hinds, David / Prince, Patricia / Thorburn, Jennifer / Mead, Henry / Kempton, Christine L. et al. | 2022
- 993
-
Optimizing the delivery of genetic and advanced diagnostic testing in the province of Ontario: challenges and implications for laboratory technology assessment and management in decentralized healthcare systemsHusereau, Don / Sullivan, Terrence / Feilotter, Harriet E. / Gomes, Marcio M. / Juergens, Rosalyn / Sheffield, Brandon S. / Kassam, Shaqil / Stockley, Tracy L. / Jacobs, Philip et al. | 2022
- 1005
-
Utilities associated with stoma-related complications: peristomal skin complications and leakagesRolls, Natasha / Yssing, Cecilie / Bøgelund, Mette / Håkan-Bloch, Jonas / de Fries Jensen, Lasse et al. | 2022
- 1015
-
Evaluation of the health economic impact of initial diagnostic modality selection in patients suspected of having HCC in China and the USABlankenburg, Michael / Elhamamy, Mostafa / Zhang, Diana / Corbin, Alice / Jin, Guanyi / Harris, James / Knobloch, Gesine et al. | 2022
- 1030
-
Reductions in acute medication use and healthcare resource utilization in patients with chronic migraine: a secondary analysis of a phase 3, randomized, double-blind, placebo-controlled study of galcanezumab with open-label extension (REGAIN)Tobin, Joshua A. / Joshi, Shivang / Ford, Janet H. / Nichols, Russell M. / Foster, Shonda A. / Ruff, Dustin / Detke, Holland C. / Aurora, Sheena K. et al. | 2022
- 1039
-
Public health impact of booster vaccination against COVID-19 in the UK during Delta variant dominance in autumn 2021Mendes, Diana / Chapman, Ruth / Gal, Peter / Atwell, Jessica / Nguyen, Jennifer L. / Hamson, Libby / Di Fusco, Manuela / Czudek, Carole / Yang, Jingyan et al. | 2022
- 1051
-
Cost-utility and cost-benefit analysis of TAVR availability in the US severe symptomatic aortic stenosis patient populationSevilla, J. P. / Klusty, Jessica M. / Song, Younghwan / Russo, Mark J. / Thompson, Christin A. / Jiao, Xiayu / Clancy, Seth J. / Bloom, David E. et al. | 2022
- 1061
-
Burden of influenza in patients with cardiovascular disease who receive antiviral treatment for influenzaCorral, Mitra / Castro, Rita de Cassia / To, Tu My / Arndorfer, Stella / Wang, Shu / Stephens, John et al. | 2022
- 1068
-
Cost-minimization analysis of recombinant factor VIII Fc versus emicizumab for treating patients with hemophilia A without inhibitors in EuropeMancuso, Maria Elisa / Castaman, Giancarlo / Pochopien, Michal / Aballéa, Samuel / Drzewiecka, Aleksandra / Hakimi, Zalmai / Nazir, Jameel / Fatoye, Francis et al. | 2022
- 1076
-
Evaluating the cost-utility of a direct transfer to angiosuite protocol within 6 h of symptom onset in suspected large vessel occlusion patientsRequena, Manuel / Seguel-Ravest, Valeska / Vilaseca-Jolonch, Andreu / Woods, Jacklyn / Guijarro, Pablo / Ribo, Marc / Tomasello, Alejandro / Molina, Carlos A. et al. | 2022
- 1085
-
Impact of non-adherence to direct oral anticoagulants amongst Swedish patients with non-valvular atrial fibrillation: results from a real-world cost-utility analysisBlomström Lundqvist, Carina / Själander, Sara / Garcia Rodriguez, Luis A. / Åkerborg, Örjan / Jin, Guanyi / Caleyachetty, Amrit / Huelsebeck, Maria / Bowrin, Kevin / Schaefer, Bernhard / Mahdessian, Hovsep et al. | 2022
- 1092
-
Cost-effectiveness of vibegron for the treatment of overactive bladder in the United StatesChen, Jing Voon / Klein, Timothy M. / Nesheim, Jeffrey / Mudd, Paul N.Jr et al. | 2022
- 1101
-
Economic evaluation of a vision-based patient monitoring and management system in addition to standard care for adults admitted to psychiatric intensive care units in EnglandMalcolm, Robert / Shore, Judith / Stainthorpe, Angela / Ndebele, Faith / Wright, Kay et al. | 2022
- 1110
-
Place of care and costs associated with acute episodes and remission in bipolar I disorderMcIntyre, Roger S. / Higa, Sara / Doan, Quan V. / Amari, Diana / Oliveri, David / Gillard, Patrick / Harrington, Amanda et al. | 2022
- 1118
-
Estimating the impact of biosimilar entry on prices and expenditures in rheumatoid arthritis: a case study of targeted immune modulatorsMaksabedian Hernandez, Ervant J. / Graf, Marlon / Portelli, Alexandria / Shafrin, Jason et al. | 2022
- 1127
-
The potential clinical impact of implementing different COVID-19 boosters in fall 2022 in the United StatesKohli, Michele A. / Maschio, Michael / Lee, Amy / Fust, Kelly / Van de Velde, Nicolas / Buck, Philip O. / Weinstein, Milton C. et al. | 2022
- 1140
-
Heterogeneity of the long-term economic burden of severe sickle cell disease: a 5-year longitudinal analysisGallagher, Meghan E. / Chawla, Anjulika / Brady, Brenna L. / Badawy, Sherif M. et al. | 2022
- 1149
-
Budget impact analysis of a bioprosthetic valve with a novel tissue versus mechanical aortic valve replacement in patients older than 65 years with aortic stenosis in Saudi ArabiaCarapinha, João L. / Al-Omar, Hussain A. / Aluthman, Uthman / Albacker, Turki B. / Arafat, Amr / Algarni, Khaled / Martí-Sánchez, Belén et al. | 2022
- 1158
-
Characterizing attributes of innovation of technologies for healthcare: a systematic reviewSyeed, M. Sakil / Poudel, Nabin / Ngorsuraches, Surachat / Veettil, Sajesh K. / Chaiyakunapruk, Nathorn et al. | 2022
- 1167
-
Beyond medicines’ barriers: exploring the true cost of multiple myelomaChoon-Quinones, Mimi / Zelei, Tamás / Barnett, Mike / Keown, Paul / Durie, Brian / Kaló, Zoltán / Almási, Tímea / Harousseau, Jean-Luc / Hose, Dirk et al. | 2022
- 1176
-
Measurement and valuation of the attributes of innovation of healthcare technologies: a systematic reviewSyeed, M. Sakil / Poudel, Nabin / Ngorsuraches, Surachat / Diaz, Jose / Chaiyakunapruk, Nathorn et al. | 2022
- 1185
-
Moving preinduction cervical ripening to a lower acuity inpatient setting using the synthetic hygroscopic cervical dilator: a cost-consequence analysis for the United StatesSaunders, Sita J. / Grisamore, Jody L. / Wong, Tess / Torrejon Torres, Rafael / Saunders, Rhodri / Einerson, Brett et al. | 2022
- 1199
-
Healthcare resource utilization and costs of cardiovascular events in patients with atherosclerotic cardiovascular disease in Germany – results of a claims database studySidelnikov, Eduard / Dornstauder, Eugen / Jacob, Christian / Maas, Christopher / Pinto, Lionel / Leidl, Reiner / Ahrens, Ingo et al. | 2022
- 1207
-
Economic evaluation of a vision-based patient monitoring and management system in an acute adult and an older adult mental health hospital in EnglandMalcolm, Robert / Shore, Judith / Stainthorpe, Angela / Ndebele, Faith / Wright, Kay et al. | 2022
- 1218
-
Comparison of utilization and cost of healthcare services and pharmacotherapy following implantation of vagus nerve stimulation vs. responsive neurostimulation or deep brain stimulation for the treatment of drug-resistant epilepsy: analyses of a large United States healthcare claims databaseVincent, Tom / Li, Qian / Zhang, Lu / Stokes, Michael / Danielson, Vanessa / Murphy, Joanna / Barion, Francesca / Lam, Sandi / Lassagne, Reginald / Berger, Ariel et al. | 2022
- 1231
-
The humanistic and economic burden of atopic dermatitis among adults and adolescents in Saudi ArabiaElezbawy, Baher / Fasseeh, Ahmad Nader / Fouly, Essam / Esba, Laila Carolina Abu / Al Abdulkarim, Hana / Al-Haddab, Mohammed / Al-Sheikh, Afaf / Altawil, Esraa / Al Turaiki, Abdulrahman / Eshmawi, Maysa et al. | 2022
- 1240
-
Cost-effectiveness of 20-valent pneumococcal conjugate vaccine in Denmark compared with PPV23Olsen, Jens / Schnack, Henrik / Skovdal, Mette / Vietri, Jeffrey / Mikkelsen, Malene Buch / Poulsen, Peter Bo et al. | 2022
- 1255
-
Clinical and economic evaluation of a proteomic biomarker preterm birth risk predictor: cost-effectiveness modeling of prenatal interventions applied to predicted higher-risk pregnancies within a large and diverse cohortBurchard, Julja / Markenson, Glenn R. / Saade, George R. / Laurent, Louise C. / Heyborne, Kent D. / Coonrod, Dean V. / Schoen, Corina N. / Baxter, Jason K. / Haas, David M. / Longo, Sherri A. et al. | 2022